OptimizeRx (NASDAQ:OPRX) & Micromobility.com (NASDAQ:MCOM) Head-To-Head Comparison

OptimizeRx (NASDAQ:OPRXGet Free Report) and Micromobility.com (NASDAQ:MCOMGet Free Report) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Insider & Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 11.4% of Micromobility.com shares are owned by institutional investors. 4.4% of OptimizeRx shares are owned by company insiders. Comparatively, 0.3% of Micromobility.com shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares OptimizeRx and Micromobility.com’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $78.21 million 1.95 -$17.57 million ($1.02) -8.18
Micromobility.com $13.16 million 0.04 -$62.06 million N/A N/A

OptimizeRx has higher revenue and earnings than Micromobility.com.

Profitability

This table compares OptimizeRx and Micromobility.com’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx -23.10% -6.96% -5.53%
Micromobility.com -378.85% N/A -208.01%

Analyst Ratings

This is a summary of recent ratings and recommmendations for OptimizeRx and Micromobility.com, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 0 1 6 0 2.86
Micromobility.com 0 0 0 0 N/A

OptimizeRx currently has a consensus price target of $15.50, indicating a potential upside of 85.85%. Given OptimizeRx’s higher possible upside, equities analysts plainly believe OptimizeRx is more favorable than Micromobility.com.

Volatility and Risk

OptimizeRx has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Micromobility.com has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500.

Summary

OptimizeRx beats Micromobility.com on 10 of the 11 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Micromobility.com

(Get Free Report)

Micromobility.com Inc., an intra-urban transportation company, provides micro-mobility services in Italy and the United States. The company operates through Mobility, Media, and All Other segments. It offers e-scooters, e- bicycles, and e-mopeds. The company provides a sharing economy that allows users to rent electric vehicles directly from the Helbiz mobile application. It is also involved in the acquisition, commercialization, and distribution of contents, such as live sport events; and provision of Helbiz Kitchen, a delivery-only ghost kitchen restaurant that specializes in preparing meals. The company was founded in 2015 and is headquartered in New York, New York.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.